Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05069012 · ClinicalTrials.gov registry record · Phase 4
Intrathecal Morphine for Cesarean Delivery
A Phase 4 study of Postoperative Pain, sponsored by Beth Israel Deaconess Medical Center.
- Completed
- Registry status
- Phase 4
- Development phase
- 72
- Enrollment target
- 1
- Study location
NCT05069012 is a Phase 4 study of Postoperative Pain that has completed, run by Beth Israel Deaconess Medical Center. The registered enrollment target is 72 participants, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05069012, a Phase 4 study of Postoperative Pain, has completed, sponsored by Beth Israel Deaconess Medical Center.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 72 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a randomized double blinded non-inferiority study comparing the duration of pain relief when patients receive one of three doses of spinal morphine. Enrolled patients will be randomly assigned to receive either 50 mcg, 150 mcg, or 250 mcg. All patients will receive standardized postoperative care, including multimodal analgesia. The primary outcome will be the time until the patient requests additional opioid pain medications.
Conditions Studied
Interventions
- DRUG Morphine Sulfate
Study Locations (1)
Massachusetts
- Beth Israel Deaconess Medical Center - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 72 participants |
| Start Date | 2021-11-15 |
| Est. Completion | 2022-07-23 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05069012
The ClinicalTrials.gov registry entry for NCT05069012 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 72 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 230-participant average among 63 other Postoperative Pain trials with a reported enrollment target (69% lower). The listed sponsor is Beth Israel Deaconess Medical Center, which has 488 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which Morphine Sulfate is the first listed.
NCT05069012 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT05069012 about?
NCT05069012 is a clinical study titled "Intrathecal Morphine for Cesarean Delivery". This is a randomized double blinded non-inferiority study comparing the duration of pain relief when patients receive one of three doses of spinal morphine. Enrolled patients will be randomly assigned to receive either 50 mcg, 150 mcg, or 250 mcg. All patients will receive standardized postoperative...
What is the current status of trial NCT05069012?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 72 participants. The study started on 2021-11-15. Estimated completion is 2022-07-23.
What conditions does trial NCT05069012 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT05069012?
The interventions under investigation include: Morphine Sulfate (DRUG).
Who is sponsoring clinical trial NCT05069012?
This trial is sponsored by Beth Israel Deaconess Medical Center, which has 488 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05069012 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Paracervical Injection and Opioid Use After Vaginal Hysterectomy for Prolapse
RECRUITING · Phase 4
-
QL Block in Laparoscopic Myomectomy
RECRUITING · Phase 4
-
Ketamine for Pain, Opioid Use, and Mental Health in Orthopedic Trauma Patients
RECRUITING · Phase 4
-
No Opioids vs. Minimal Opioids Following Inguinal Hernia Repair
ACTIVE NOT RECRUITING · Phase 4
-
Single-shot TAP Block vs Continuous TAP Block
COMPLETED · Phase 4
-
Pain Control With Total Knee Replacement
COMPLETED · Phase 4
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.